Dr Kenneth Micklethwaite

Related Grants and Projects

• Principal investigator of A Phase I Study of Autologous CD19 Specific Chimeric Antigen Receptor T-cells for Therapy of Relapsed and Refractory B-cell Leukaemia and Lymphoma (The Auto-CAR19 Trial). (funded by National Health and Medical Research Council)
• Principal investigator of A Phase I Study of PiggyBac CD19 Specific Chimeric Antigen Receptor T-cells for Therapy of Persistent and Relapsed B-cell Leukaemia and Lymphoma Post Allogeneic Stem Cell Transplantation (The CARTELL Study). (funded by National Health and Medical Research Council)
• Principal investigator of Redirecting T-cells for immunotherapy of leukaemia and lymphoma by the expression of a CD19-specific chimeric antigen receptor using the PiggyBac transposon gene modification system (funded by National Health and Medical Research Council)